Loading clinical trials...
Loading clinical trials...
A Phase 1, First Time in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of NST 6179 in Healthy Subjects
Conditions
Interventions
NST 6179
Placebo
Locations
1
United Kingdom
Covance Clinical Research Unit, Ltd
Leeds, United Kingdom
Start Date
November 11, 2021
Primary Completion Date
May 27, 2022
Completion Date
May 27, 2022
Last Updated
June 24, 2024
NCT07197944
NCT05561647
NCT06274788
NCT06973304
NCT06427642
NCT06938542
Lead Sponsor
NorthSea Therapeutics B.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions